PROCEPT BioRobotics Corporation
PRCT
$40.52
$1.213.08%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 55.71% | 59.36% | 64.84% | 71.71% | 73.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 55.71% | 59.36% | 64.84% | 71.71% | 73.74% |
| Cost of Revenue | 23.18% | 27.72% | 34.17% | 52.30% | 60.48% |
| Gross Profit | 82.62% | 86.89% | 92.96% | 89.65% | 86.48% |
| SG&A Expenses | 35.36% | 32.41% | 30.09% | 31.22% | 31.98% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.12% | 30.50% | 30.87% | 38.58% | 41.15% |
| Operating Income | 16.31% | 11.10% | 11.50% | -1.73% | -8.40% |
| Income Before Tax | 18.86% | 12.75% | 13.68% | 6.10% | 0.81% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 18.86% | 12.75% | 13.68% | 6.10% | 0.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 18.86% | 12.75% | 13.68% | 6.10% | 0.81% |
| EBIT | 16.31% | 11.10% | 11.50% | -1.73% | -8.40% |
| EBITDA | 18.03% | 12.82% | 13.27% | 0.13% | -6.58% |
| EPS Basic | 24.37% | 19.88% | 21.67% | 16.25% | 11.56% |
| Normalized Basic EPS | 24.37% | 19.87% | 21.66% | 13.54% | 8.71% |
| EPS Diluted | 24.37% | 19.88% | 21.67% | 16.25% | 11.56% |
| Normalized Diluted EPS | 24.37% | 19.87% | 21.66% | 13.54% | 8.71% |
| Average Basic Shares Outstanding | 7.28% | 8.88% | 10.24% | 11.96% | 12.19% |
| Average Diluted Shares Outstanding | 7.28% | 8.88% | 10.24% | 11.96% | 12.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |